Table 1 Baseline characteristics according to extracellular fluid excess status.
ECF excess status | p-value | |||
|---|---|---|---|---|
Normal | Mild | Severe | ||
N, % | 123 (43.3) | 90 (31.7) | 71 (25) | |
Age, years | 56.19 ± 14.59 | 65.51 ± 11.58† | 66.51 ± 10.67‡ | < 0.001* |
Sex, male, n (%) | 87 (70.7) | 43 (47.8) | 37 (52.1) | 0.001* |
Smoking status, n (%) | 0.007* | |||
Non | 55 (44.7) | 55 (61.1) | 45 (63.4) | |
Ex-smoker | 46 (37.4) | 30 (33.3) | 22 (31.0) | |
Smoker | 22 (17.9) | 5 (5.6) | 4 (5.6) | |
BMI, kg/m2 | 26.21 ± 4.08 | 24.96 ± 4.04 | 24.13 ± 3.84‡ | 0.002* |
HTN (n, %) | 112 (91.1) | 77 (85.6) | 58 (81.7) | 0.16 |
DM (n, %) | 71 (57.7) | 61 (67.8) | 40 (56.3) | 0.23 |
SBP, mmHg | 126.04 ± 19.21 | 130.73 ± 17.74 | 137.69 ± 21.86‡ | < 0.001* |
eGFR, mL/min/1.73 m2 | 52.55 ± 22.30 | 43.97 ± 22.61† | 32.26 ± 21.63‡§ | < 0.001* |
LDL-cholesterol, mg/dL | 92.91 ± 27.14 | 91.65 ± 31.04 | 99.00 ± 33.80 | 0.29 |
CRP, mg/dL | 4.82 ± 13.79 | 1.85 ± 2.49 | 3.47 ± 8.92 | 0.13 |
CKD stage, n (%) | < 0.001* | |||
1 | 0 (0) | 0 (0) | 6 (8.5) | |
2 | 48 (39.0) | 22 (24.4) | 6 (8.5) | |
3 | 49 (39.8) | 31 (34.4) | 17 (23.9) | |
4 | 25 (20.3) | 35 (38.9) | 33 (46.5) | |
5 | 1 (0.8) | 2 (2.2) | 9 (12.7) | |
HbA1c, mmol/mol | 6.37 ± 1.05 | 6.40 ± 0.96 | 6.38 ± 1.09 | 0.97 |
DR grade, n (%) | 0.09 | |||
No DR | 55 (77.5) | 41 (67.2) | 21 (52.5) | |
NPDR | 8 (11.3) | 12 (19.7) | 12 (30.0) | |
PDR | 8 (11.3) | 8 (13.1) | 7 (17.5) | |
ECW/TBW | 0.377 ± 0.018 | 0.392 ± 0.004† | 0.414 ± 0.051‡§ | < 0.001* |
OCT parameters | ||||
CVI, % | 66.75 ± 3.11 | 65.85 ± 2.78 | 64.37 ± 3.06‡§ | < 0.001* |
Luminal area | 177.93 ± 103.38 | 173.15 ± 106.83 | 141.59 ± 89.58 | 0.05 |
Stromal area | 88.18 ± 49.67 | 89.01 ± 56.34 | 76.81 ± 46.67 | 0.25 |
SFCT, μm | 277.03 ± 85.35 | 259.98 ± 87.91 | 228.24 ± 80.02‡ | 0.001* |